
An abstract from the American Heart Association's Scientific Sessions 2026 reveals the continuous expansion of the GLP-1 medication class.
The Society of Thoracic Surgeons (STS) has updated its clinical practice guidelines on use of antiplatelet drugs during heart surgery.






